Skip to main content
H.R. 1002 117th Congress House

DEBAR Act of 2021

Official title: To amend the Controlled Substances Act to authorize the debarment of certain registrants, and for other purposes.

Introduced: February 11, 2021 Introduced by: Robert E. Latta Republican · Ohio See on congress.gov
Crime and Law Enforcement Administrative remediesDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrations
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

 Everywhere this bill has been 18 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 6, 2021
Became Public Law No: 117-36.
Aug 6, 2021
Signed by President.
Aug 4, 2021
Presented to President.
Jul 28, 2021
Message on Senate action sent to the House.
Jul 27, 2021
Passed Senate without amendment by Unanimous Consent. (consideration: CR S5111)
Jul 27, 2021
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5111)
Jul 27, 2021
Senate Committee on the Judiciary discharged by Unanimous Consent.
Apr 19, 2021
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Apr 15, 2021
Motion to reconsider laid on the table Agreed to without objection.
Apr 15, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 5 (Roll no. 112). (text: 04/14/2021 CR H1763)
Apr 15, 2021
Considered as unfinished business. (consideration: CR H1831-1832)
Apr 14, 2021
Considered under suspension of the rules. (consideration: CR H1763-1764)
Apr 14, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Apr 14, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 14, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 1002.
Feb 12, 2021
Referred to the Subcommittee on Health.
Feb 11, 2021
Introduced in House
Feb 11, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Apr 15, 2021 House · vote #112 On Motion to Suspend the Rules and Pass, as Amended Passed 411–5 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action August 6, 2021

Became Public Law No: 117-36.

 Plain-English summary Congressional Research Service

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021

This bill authorizes the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances under certain circumstances.

Specifically, the DEA may bar—temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration, and (2) has a history of prior suspensions or revocations.

 Related & companion bills 2
 Bill text 5 versions
 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1002: DEBAR Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1002/
MLA
"H.R. 1002: DEBAR Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1002/.
Bluebook (legal)
H.R. 1002, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1002/.
Markdown link
[H.R. 1002: DEBAR Act of 2021](https://openamerica.io/bill/117-HR-1002/)
Report a problem